Patent · US Active

Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof

US12318366B2 · kind B2 · utility

0Cited by

4References

39Claims

0Family size

Assignee

HUA Medicine (Shanghai) Ltd. · CN

Inventors

Li Chen · Shanghai, CN
Yongguo Li · Shanghai, CN
Gaosen Wang · Shanghai, CN

Key dates

Filing date	May 28, 2019
Grant date	Jun 3, 2025
Priority date	—
Expiry date	Jan 18, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical combination. The pharmaceutical combination contains a glucokinase activator or a pharmaceutically acceptable salt thereof, an isotopic marker thereof, a crystalline form thereof, a hydrate, a solvate, a diastereoisomer or an enantiomer form, and a biguanide hypoglycemic drug. A pharmaceutical composition and a fixed dose combination preparation as well as a preparation method and use of the pharmaceutical composition and the fixed dose combination preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.